featured
Safety and Efficacy of Allogeneic HSCT After PD-1 Blockade
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant After PD-1 Blockade in Relapsed/Refractory Lymphoma
Blood 2017 Jan 10;[EPub Ahead of Print], RW Merryman, HT Kim, PL Zinzani, C Carlo-Stella, SM Ansell, MA Perales, A Avigdor, AS Halwani, R Houot, T Marchand, N Dhedin, W Lescaut, A Thiebaut-Bertrand, S François, A Stamatoullas-Bastard, PS Rohrlich, H Labussière Wallet, L Castagna, A Santoro, V Bachanova, SC Bresler, A Srivastava, H Kim, E Pesek, M Chammas, C Reynolds, VT Ho, JH Antin, J Ritz, RJ Soiffer, P ArmandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.